Transforming Drug Development: The Promise of Real-Time Clinical Trials
The FDA commissioner highlights how real-time clinical trials could change the landscape of drug development by providing regulators with immediate data insights.
Editorial Staff
1 min read
Updated 11 days ago
The FDA commissioner has emphasized the potential of real-time clinical trials to revolutionize the drug development process.
This approach would allow regulators to monitor clinical trials as they unfold, accessing endpoint data in real-time via cloud technology.
Such advancements could lead to more informed regulatory decisions and potentially accelerate the approval of new therapies.